The HealthTech Innovation Days (HTID) will take place on October 5th and 6th , as an in-person meeting in Paris and virtually for international participants.
The objective of this event is to foster collaborations within the European health and life sciences ecosystem. At the HTID participants can attend round-table discussions on economic and political issues that impact the development of medical technologies as well as discuss new trends in research and development, particularly in the field of gene and cell therapies, in order to accelerate access to new therapeutic solutions for patients.
For this second edition, over 130 European Healthtech companies and 300 international investors, based in Europe, North America, Australia, Asia, and the Middle East will attend the event. Alongside them, over 15 major pharmaceutical groups have confirmed their presence, including Servier, as a sponsor of the event.
The economic impact of Covid-19 on healthcare systems and the measures deployed by the sector will be at the heart of the discussions of this 2020 edition. Eric Falcand, Global Head of Business Development & Licensing at Servier, will moderate a round-table on: Facing Covid-19: challenges for Biotech and Pharma
“It is essential to contribute to the development of the healthcare ecosystem in Europe” underlines Eric Falcand. “We are very pleased to sponsor, once again, this second edition of the HealthTech Innovation Days. It is a unique opportunity to discuss with healthcare players with a view to accelerating innovation for the benefit of patients.”
For further information on the program and the event: http://www.htid-paris.com